| scholarly article | Q13442814 |
| P50 | author | Eva Csizmadia | Q77369283 |
| Christopher J Longo | Q97555129 | ||
| P2093 | author name string | Christiane Ferran | |
| Soizic Daniel | |||
| Virendra I. Patel | |||
| Shane T. Grey | |||
| David W. Sun | |||
| Gautam V. Shrikhande | |||
| Maria B. Arvelo | |||
| Salvatore T. Scali | |||
| P2860 | cites work | I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 |
| De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling | Q24299573 | ||
| Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice | Q24616207 | ||
| A model to predict survival in patients with end-stage liver disease | Q28199900 | ||
| A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism | Q28282198 | ||
| Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
| CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy | Q28584735 | ||
| The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury | Q28590283 | ||
| TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB | Q29614706 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| Liver regeneration | Q29614743 | ||
| Targets of the cyclin-dependent kinase Cdk1 | Q29616479 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats | Q30960436 | ||
| A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis | Q33183441 | ||
| A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation | Q33204720 | ||
| Liver regeneration | Q33870218 | ||
| NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases | Q33930920 | ||
| Complete reconstitution of mouse liver with xenogeneic hepatocytes | Q34276520 | ||
| Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration | Q34368036 | ||
| Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor | Q35997495 | ||
| Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms | Q36001216 | ||
| A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets | Q36375424 | ||
| NFkappaB prevents apoptosis and liver dysfunction during liver regeneration | Q37378197 | ||
| Regenerating livers of old rats contain high levels of C/EBPalpha that correlate with altered expression of cell cycle associated proteins | Q39724437 | ||
| Fulminant hepatic failure. Presumable contribution to halothane | Q40944537 | ||
| Severe liver degeneration in mice lacking the IkappaB kinase 2 gene | Q40962152 | ||
| Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. | Q43508041 | ||
| Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased | Q43722495 | ||
| Interleukin 6 is important for survival after partial hepatectomy in mice | Q45233229 | ||
| Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia | Q45871954 | ||
| Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. | Q46013733 | ||
| Long-term results of pediatric liver transplantation: an analysis of 569 transplants | Q46048992 | ||
| Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. | Q52522262 | ||
| In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. | Q52531947 | ||
| MINIMUM GRAFT VOLUME FOR SUCCESSFUL ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE | Q58236334 | ||
| Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration | Q70988072 | ||
| Acute liver failure | Q72766177 | ||
| Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration | Q73107788 | ||
| Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver | Q74510381 | ||
| Blood coagulation | Q77631135 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatectomy | Q1514021 |
| Tumor necrosis factor, alpha-induced protein 3 | Q21991285 | ||
| P304 | page(s) | 156–164 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism | |
| P478 | volume | 42 |
| Q36352736 | A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis |
| Q38714253 | A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses |
| Q33855522 | A20 modulates lipid metabolism and energy production to promote liver regeneration |
| Q40241237 | A20 overexpression under control of mouse osteocalcin promoter in MC3T3-E1 cells inhibited tumor necrosis factor-alpha-induced apoptosis |
| Q37482764 | A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death |
| Q36767167 | A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals |
| Q33514016 | A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression |
| Q39574742 | A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling |
| Q36251372 | A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression |
| Q40040670 | A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes. |
| Q41526866 | A20/TNFAIP3 Discriminates Tumor Necrosis Factor (TNF)-Induced NF-κB from JNK Pathway Activation in Hepatocytes |
| Q40171629 | A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. |
| Q53810154 | Anti-inflammatory and anti-osteoclastogenic effects of zinc finger protein A20 overexpression in human periodontal ligament cells. |
| Q36249226 | Comprehensive CircRNA expression profile and selection of key CircRNAs during priming phase of rat liver regeneration |
| Q33889005 | Elevated serum A20 is associated with severity of chronic hepatitis B and A20 inhibits NF-κB-mediated inflammatory response |
| Q37362507 | Galectin-1 is essential for efficient liver regeneration following hepatectomy |
| Q40543951 | Hypothermia predicts hepatic failure after extensive hepatectomy in mice |
| Q51795648 | Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. |
| Q38410812 | New gene therapy strategies for hepatic fibrosis |
| Q36751548 | Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration |
| Q43492573 | Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. |
| Q47308542 | The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis |
| Q37325921 | Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts |
| Q37777694 | What is critical for liver surgery and partial liver transplantation: size or quality? |
| Q36105534 | Zinc finger protein A20 protects rats against chronic liver allograft dysfunction |
Search more.